407 related articles for article (PubMed ID: 22149934)
1. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
Kassa J; Kunesova G
Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats.
Kassa J; Karasova JZ; Tesarova S
Drug Chem Toxicol; 2011 Jul; 34(3):233-9. PubMed ID: 21649476
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
[TBL] [Abstract][Full Text] [Related]
5. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
Kassa J; Karasova JZ; Sepsova V; Caisberger F
Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):30-4. PubMed ID: 21235715
[TBL] [Abstract][Full Text] [Related]
6. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Bajgar J
Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
[TBL] [Abstract][Full Text] [Related]
7. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
Kassa J; Karasova JZ; Tesarova S; Musilek K; Kuca K; Jung YS
Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):861-7. PubMed ID: 22545968
[TBL] [Abstract][Full Text] [Related]
8. A comparison of neuroprotective efficacy of two novel reactivators of acetylcholinesterase called K920 and K923 with the oxime K203 and trimedoxime in tabun-poisoned rats.
Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J
Toxicol Mech Methods; 2017 Mar; 27(3):236-243. PubMed ID: 28043192
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Karasova J
Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392
[TBL] [Abstract][Full Text] [Related]
10. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats.
Kassa J; Kunesova G
J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727
[TBL] [Abstract][Full Text] [Related]
11. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
Kassa J; Misik J; Hatlapatkova J; Zdarova Karasova J; Sepsova V; Caisberger F; Pejchal J
Molecules; 2017 Jul; 22(7):. PubMed ID: 28696367
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
[TBL] [Abstract][Full Text] [Related]
13. The benefit of combinations of oximes for the ability of antidotal treatment to counteract sarin-induced brain damage in rats.
Caisberger F; Pejchal J; Misik J; Kassa J; Valis M; Kuca K
BMC Pharmacol Toxicol; 2018 Jun; 19(1):35. PubMed ID: 29954446
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the ability of newly-developed bispyridinium oxime K203 and currently available oximes (trimedoxime, obidoxime, HI-6) to counteract the acute neurotoxicity of soman in rats.
Kassa J; Karasova JZ; Tesarova S; Kuca K; Musilek K
Toxicol Mech Methods; 2010 Oct; 20(8):445-51. PubMed ID: 20738156
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of the neuroprotective effects of bispyridinium oximes in tabun-poisoned rats.
Kassa J; Karasova J
J Toxicol Environ Health A; 2007 Sep; 70(18):1556-67. PubMed ID: 17710615
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats.
Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the neuroprotective efficacy of pharmacological pretreatment and antidotal treatment in soman-poisoned rats.
Kassa J; Krejcová G; Samnaliev I
Acta Medica (Hradec Kralove); 2003; 46(3):101-7. PubMed ID: 14677718
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the potency of two novel bispyridinium oximes (K456, K458) in comparison with oxime K203 and trimedoxime to counteract tabun-induced neurotoxicity in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):201-8. PubMed ID: 23647829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
